DMTX
Income statement / Annual
Last year (2016), Dimension Therapeutics, Inc.'s total revenue was $11.47 M,
an increase of 48.01% from the previous year.
In 2016, Dimension Therapeutics, Inc.'s net income was -$49.00 M.
See Dimension Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$11.47 M |
$7.75 M |
| Cost of Revenue |
$0.00
|
$0.00
|
| Gross Profit |
$11.47 M
|
$7.75 M
|
| Gross Profit Ratio |
1
|
1
|
| Research and Development Expenses |
$47.74 M
|
$33.99 M
|
| General & Administrative Expenses |
$12.78 M
|
$8.72 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$12.78 M
|
$8.72 M
|
| Other Expenses |
$0.00
|
$0.00
|
| Operating Expenses |
$60.52 M
|
$42.72 M
|
| Cost And Expenses |
$60.52 M
|
$42.72 M
|
| Interest Income |
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.62 M
|
$716.00 K
|
| EBITDA |
-$47.39 M |
-$34.34 M |
| EBITDA Ratio |
-4.13
|
-4.43
|
| Operating Income Ratio |
-4.28
|
-4.51
|
| Total Other Income/Expenses Net |
$49.00 K
|
-$91.00 K
|
| Income Before Tax |
-$49.00 M
|
-$35.06 M
|
| Income Before Tax Ratio |
-4.27
|
-4.52
|
| Income Tax Expense |
$49.00 K
|
-$91.00 K
|
| Net Income |
-$49.00 M
|
-$35.06 M
|
| Net Income Ratio |
-4.27
|
-4.52
|
| EPS |
-1.96 |
-1.4 |
| EPS Diluted |
-1.96 |
-4.41 |
| Weighted Average Shares Out |
$25.02 M
|
$25.02 M
|
| Weighted Average Shares Out Diluted |
$25.02 M
|
$7.95 M
|
| Link |
|
|
